Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use South Africa2017/06155Filed on 2016-03-18
NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE US Patent 10,562,960Filed on 2017-09-19
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use European Patent16716979.6Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use China201680028822.8Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use Canada2980005Filed on 2016-03-18
Neutralizing Antibodies to GP120 and Their Use Read more about Neutralizing Antibodies to GP120 and Their Use Australia2016235541Filed on 2016-03-18
TREATMENT OF TUMORS BY INHIBITION OF CD300F Read more about TREATMENT OF TUMORS BY INHIBITION OF CD300F Patent Cooperation TreatyPCT/US2017/056192Filed on 2017-10-11
METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE Read more about METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE Patent Cooperation TreatyPCT/US2017/051413Filed on 2017-09-13
DETECTION OF INFECTIOUS PRION PROTEIN BY SEEDED CONVERSION OF RECOMBINANT PRION PROTEIN Read more about DETECTION OF INFECTIOUS PRION PROTEIN BY SEEDED CONVERSION OF RECOMBINANT PRION PROTEIN US Application 15/665,323Filed on 2017-07-31